{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:02:47Z","timestamp":1767769367727,"version":"3.48.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020297","name":"Abiomed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe aortic stenosis (AS) is associated with an increased risk of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI). While Impella-supported high-risk PCI (HRPCI) has demonstrated improved outcomes, its safety in patients with AS remains inadequately established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We evaluated the effectiveness and safety of Impella support in patients with AS undergoing HRPCI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients from the PROTECT III study (NCT04136392), a single-arm, FDA-audited, multicenter investigation of Impella-supported HRPCI, were assessed. AS severity was classified as none\/trivial, mild, moderate, or severe. The primary outcome was 90-day major adverse cardiac and cerebrovascular events [MACCE, defined as the composite of all-cause mortality, MI, stroke\/transient ischemic attack (TIA), and revascularization]. Secondary outcomes included in-hospital complications, stroke\/TIA, and vascular complications requiring surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 594 patients with available echocardiographic data, 490 had none\/trivial AS, while 34, 24, and 46 had mild, moderate, or severe AS, respectively. Patients with AS were older, had fewer incidences of diabetes, were more likely to have left main disease, and had higher left ventricular ejection fraction. Severely calcified lesions and atherectomy were more frequent among patients with moderate or severe AS. No significant differences were observed in PCI-related complications, stroke\/TIA, and 30-day or 90-day MACCE across AS severity groups. However, transfusion rates were higher in patients with AS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients undergoing Impella-supported HRPCI, 90-day MACCE and PCI-related complications were similar across all levels of AS severity. These findings suggest that the procedure is safe in this complex, high-risk population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Information<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Trial Name<\/jats:italic>\n                      : The Global cVAD Study (cVAD). ClinicalTrial.gov URL:\n                      <jats:ext-link>https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04136392?term=cvad&amp;amp;draw=2&amp;amp;rank=2<\/jats:ext-link>\n                      . ClinicalTrial.gov Identifier: NCT04136392.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1638259","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:59:54Z","timestamp":1767769194000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes of aortic stenosis patients undergoing Impella-supported high-risk percutaneous coronary intervention"],"prefix":"10.3389","volume":"12","author":[{"given":"Poonam","family":"Velagapudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Bellumkonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra J.","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsalan","family":"Abu-Much","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia B.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Schonning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjorn","family":"Redfors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy L.","family":"Grines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneel S.","family":"Maini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne B.","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William W.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1161\/01.CIR.90.2.844","article-title":"Characterization of the early lesion of \u2018degenerative\u2019 valvular aortic stenosis. Histological and immunohistochemical studies","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/clc.4960141210","article-title":"Development and progression of aortic valve stenosis: atherosclerosis risk factors\u2013a causal relationship? A clinical morphologic study","volume":"14","author":"Mohler","year":"1991","journal-title":"Clin Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jacc.2019.06.012","article-title":"Coronary artery disease and transcatheter aortic valve replacement","volume":"74","author":"Faroux","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ahj.2022.02.006","article-title":"Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices","volume":"248","author":"O'Neill","year":"2022","journal-title":"Am Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.jaccas.2022.08.036","article-title":"Severe aortic stenosis with coronary disease","volume":"4","author":"Johnson Nils","year":"2022","journal-title":"JACC: Case Rep"},{"key":"B6","first-page":"688","article-title":"Safety of percutaneous coronary intervention alone in symptomatic patients with moderate and severe valvular aortic stenosis and coexisting coronary artery disease: analysis of results in 56 patients","volume":"16","author":"Kuchulakanti","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4244\/EIJ-D-18-01126","article-title":"New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis","volume":"15","author":"Ameloot","year":"2019","journal-title":"EuroIntervention"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/ccd.24303","article-title":"Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction","volume":"80","author":"Martinez","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"B9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.carrev.2020.06.003","article-title":"Balloon aortic valvuloplasty followed by impella\u00ae-assisted left main coronary artery percutaneous coronary intervention in patients with severe aortic stenosis as a bridge to transcatheter aortic valve replacement","volume":"22","author":"Diaz Quintero","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/ccd.25355","article-title":"Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis","volume":"85","author":"Spiro","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"B11","doi-asserted-by":"publisher","first-page":"101061","DOI":"10.1016\/j.jscai.2023.101061","article-title":"Feasibility and safety of impella-assisted high-risk PCI before TAVR in patients with severe aortic stenosis","volume":"2","author":"Yeo","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"B12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcin.2008.11.005","article-title":"A prospective feasibility trial investigating the use of the impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I trial): initial U.S experience","volume":"2","author":"Dixon","year":"2009","journal-title":"JACC: Cardiovasc Interv"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with impella 2.5 vs. intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.jcin.2023.04.036","article-title":"Sex differences in pLVAD-assisted high-risk percutaneous coronary intervention: insights from the PROTECT III study","volume":"16","author":"Shah","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ahj.2023.12.015","article-title":"Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI","volume":"269","author":"Abu-Much","year":"2024","journal-title":"Am Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ahj.2017.09.007","article-title":"The cVAD registry for percutaneous temporary hemodynamic support: a prospective registry of impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure","volume":"199","author":"Vetrovec","year":"2018","journal-title":"Am Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jcin.2016.02.046","article-title":"A practical approach to mechanical circulatory support in patients undergoing percutaneous coronary intervention: an interventional perspective","volume":"9","author":"Atkinson","year":"2016","journal-title":"JACC: Cardiovasc Interv"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001038","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/CIRCULATIONAHA.111.039180","article-title":"Percutaneous coronary intervention in patients with severe aortic stenosis","volume":"125","author":"Goel","year":"2012","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1038\/s41598-018-36066-z","article-title":"Anemia in patients with severe aortic stenosis","volume":"9","author":"Nagao","year":"2019","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"crossref","first-page":"A1975","DOI":"10.1016\/S0735-1097(15)61975-1","article-title":"Intravascular hemolysis in patients with aortic stenosis: evaluation by erythrocyte creatine","volume":"65","author":"Sugiura","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1638259\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:59:56Z","timestamp":1767769196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1638259\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":23,"alternative-id":["10.3389\/fcvm.2025.1638259"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1638259","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1638259"}}